Medtronic MDT Cash Flow Statement
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| $1.26B+9.5% | $1.15B-16.7% | $1.38B+31.9% | $1.05B-1.3% | $1.06B-18.6% | ||
| $716M-4.4% | $749M+0.5% | $745M-0.4% | $748M-11.0% | $840M+22.8% | ||
| $95M+1.1% | $94M-48.4% | $182M+112% | $86M-3.4% | $89M-9.2% | ||
| —— | —— | —— | $167M+171% | -$235M-70.3% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $34M-5.6% | $36M-5.3% | $38M+35.7% | $28M+3.7% | $27M-47.1% | ||
| —— | $131M-56.2% | $299M-19.8% | $373M— | —— | ||
| $123M-82.5% | $703M+486% | -$182M+69.6% | -$598M-263% | $366M-33.5% | ||
| —— | —— | $727M+56.7% | $464M— | —— | ||
| $287M+2,308% | -$13M-106% | $214M+174% | -$288M-216% | $249M+8,200% | ||
| $2.57B-6.2% | $2.74B+197% | $925M-15.0% | $1.09B-57.0% | $2.53B-1.7% | ||
| $488M+9.9% | $444M-5.1% | $468M-7.1% | $504M+9.8% | $459M-3.6% | ||
| $406M— | —— | —— | —— | —— | ||
| $2.15B-9.2% | $2.37B+12.9% | $2.1B0.0% | $2.1B-1.5% | $2.13B+2.8% | ||
| $2.12B+4.9% | $2.02B+3.9% | $1.95B-3.1% | $2.01B-10.3% | $2.24B+16.8% | ||
| —— | $24M+117% | -$139M-211% | $125M-9.4% | $138M+23.2% | ||
| -$917M-12.4% | -$816M-69.3% | -$482M+33.0% | -$719M-46.7% | -$490M+41.9% | ||
| $908M-0.3% | $911M+0.1% | $910M0.0% | $910M+1.4% | $897M0.0% | ||
| $435M+314% | $105M-71.8% | $372M+202% | $123M-55.1% | $274M+51.4% | ||
| —— | —— | $1.75B— | $0— | —— | ||
| —— | —— | $1.77B+52.2% | $1.16B— | $0— | ||
| $97M-40.9% | $164M+2.5% | $160M+68.4% | $95M-12.0% | $108M-35.7% | ||
| —— | —— | —— | $70M+125% | -$280M-275% | ||
| —— | —— | $753M+16.0% | $649M— | —— | ||
| -$888M+57.5% | -$2.09B-428% | -$395M+71.4% | -$1.38B-2.8% | -$1.34B+23.4% | ||
| $33M+37.5% | $24M— | —— | $67M-76.3% | $283M+318% | ||
| —— | -$136M— | —— | -$945M-197% | $978M+735% | ||
| $201M+548% | $31M-93.3% | $461M+469% | $81M-58.5% | $195M+261% | ||
| $344M+68.6% | $204M-79.4% | $992M+147% | $402M+32.2% | $304M+68.9% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $287M+2,308% | -$13M-106% | $214M+174% | -$288M-216% | $249M+8,200% | ||
| -$34M+69.9% | -$113M-1,313% | -$8M+95.0% | -$159M+46.3% | -$296M-164% | ||
| $34M-5.6% | $36M-5.3% | $38M+35.7% | $28M+3.7% | $27M-47.1% | ||
| —— | $24M+117% | -$139M-211% | $125M-9.4% | $138M+23.2% | ||
| $2.12B+4.9% | $2.02B+3.9% | $1.95B-3.1% | $2.01B-10.3% | $2.24B+16.8% | ||
| $134.5M0.0% | $134.5M0.0% | $134.5M0.0% | $134.5M— | $0— | ||
| —— | $164M+2.5% | $160M+68.4% | $95M-12.0% | $108M-35.7% | ||
| —— | —— | —— | $70M+125% | -$280M-275% | ||
| —— | —— | $753M+16.0% | $649M— | —— | ||
| $344M+68.6% | $204M-79.4% | $992M+147% | $402M+32.2% | $304M+68.9% | ||
| $2.09B-9.3% | $2.3B+403% | $457M-21.7% | $584M-71.8% | $2.07B-1.3% | ||
| $2.09B-9.3% | $2.3B+403% | $457M-21.7% | $584M-71.8% | $2.07B-1.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Medtronic generate?
- Medtronic (MDT) generated $7.3B in operating cash flow over the trailing twelve months.
- What is Medtronic's free cash flow?
- After $1.9B of capital expenditures, Medtronic's free cash flow was $5.4B over the trailing twelve months, up 4.7% year over year.
- Where does Medtronic's cash flow data come from?
- Every line is extracted from Medtronic's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
